Delivery Order SPE2DB24D2011-SPE2DB25FBQBY

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $41K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,279.69 firm fixed-price delivery order has a completion date of May 22, 2024 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $25,407.82 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 22, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies. This contract...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 16, 2025 with a ceiling value of $1,474.20 and an ultimate completion date of January 17, 2025. The award is a delivery order contract, with a firm fixed price pricing type. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 11, 2023, with a ceiling value of $5,032.79 and an ultimate completion date of May 12, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $11,531.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication, to the Defense Logistics Agency (DLA). The $1,264.59 firm fixed-price delivery order has a completion date of December 9, 2024 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $21,681.78 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2025, with a completion date of February 10, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S medication to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 8, 2023 with a ceiling value of $6,494.36. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 9, 2023. This contract is not designated as a set-aside....
This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 3, 2025, with a ceiling value of $28,978.09 and an ultimate completion date of January 6, 2025. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated as a...
This federal contract award is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,626.92 and is a firm fixed-price delivery order with an ultimate completion date of October 21, 2024. This contract is associated with a larger Indefinite Delivery...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB25FBQBY
    Delivery Order

This federal contract award is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2025, with a ceiling value of $41,479.53 and a completion date of February 25, 2025.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 3:19 AM